FINLIUS

Google image searchProduct monograph

Active ingredient

ustekinumab, 45 MG/0.5 ML

DIN: 02537303

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: SINGLE-USE VIAL & PREFILLED SYRINGE

Schedule: Prescription / Schedule D

Company: JANSSEN INC

Date: 02-JUL-2024

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AC — Interleukin inhibitors (ATC, ATC/DDD)
• L04AC05 — USTEKINUMAB (ATC/DDD)

Reference brand drug: Stelara

Pharmaceutical standard: MFR

External Links for Finlius

Search on Google

• Finlius side effects
• Finlius dosage
• ustekinumab side effects
• ustekinumab dosage

Janssen Inc

Go to Janssen website to see drug product details. Sometimes you can find finlius photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.